373 related articles for article (PubMed ID: 28106782)
1. From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.
Kyrochristos ID; Glantzounis GK; Ziogas DE; Gizas I; Schizas D; Lykoudis EG; Felekouras E; Machairas A; Katsios C; Liakakos T; Cho WC; Roukos DH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106782
[TBL] [Abstract][Full Text] [Related]
2.
Sinn M; Sinn BV; Treue D; Keilholz U; Damm F; Schmuck R; Lohneis P; Klauschen F; Striefler JK; Bahra M; Bläker H; Bischoff S; Pelzer U; Oettle H; Riess H; Budczies J; Denkert C
Clin Cancer Res; 2020 Jul; 26(14):3732-3739. PubMed ID: 32234756
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM
Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654
[TBL] [Abstract][Full Text] [Related]
4. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
Friedman K; Resnick MB; Safran H
R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
[TBL] [Abstract][Full Text] [Related]
5. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.
Hu HF; Ye Z; Qin Y; Xu XW; Yu XJ; Zhuo QF; Ji SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1725-1741. PubMed ID: 33574569
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing in Pancreatic Cancer.
Shen GQ; Aleassa EM; Walsh RM; Morris-Stiff G
Pancreas; 2019 Jul; 48(6):739-748. PubMed ID: 31206465
[TBL] [Abstract][Full Text] [Related]
7. Updates in Tumor Profiling in Gastrointestinal Cancers.
Perez K; Safran HP
R I Med J (2013); 2015 Oct; 98(10):21-4. PubMed ID: 26422541
[TBL] [Abstract][Full Text] [Related]
8. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing.
Herreros-Villanueva M; Bujanda L; Ruiz-Rebollo L; Torremocha R; Ramos R; Martín R; Artigas MC
Gastroenterol Hepatol; 2022 Oct; 45(8):637-644. PubMed ID: 35092761
[TBL] [Abstract][Full Text] [Related]
10. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
[TBL] [Abstract][Full Text] [Related]
11. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
12. Applying next-generation sequencing to pancreatic cancer treatment.
Mardis ER
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):477-86. PubMed ID: 22751458
[TBL] [Abstract][Full Text] [Related]
13. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
[TBL] [Abstract][Full Text] [Related]
15. Identifying the clonal origin of synchronous multifocal tumors in the hepatobiliary and pancreatic system using multi-omic platforms.
Jiang W; Ding Y; Shen Y; Fan L; Zhou L; Li Z; Zheng Y; Zhao P; Liu L; Tong Z; Fang W; Wang W
Oncotarget; 2017 Jan; 8(3):5016-5025. PubMed ID: 28008139
[TBL] [Abstract][Full Text] [Related]
16. Primary liver cancer genome sequencing: translational implications and challenges.
Ziogas DE; Kyrochristos ID; Glantzounis GK; Christodoulou D; Felekouras E; Roukos DH
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):875-883. PubMed ID: 28712319
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
[TBL] [Abstract][Full Text] [Related]
18. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
[TBL] [Abstract][Full Text] [Related]
20. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.
Lowder CY; Dhir T; Goetz AB; Thomsett HL; Bender J; Tatarian T; Madhavan S; Petricoin EF; Blais E; Lavu H; Winter JM; Posey J; Brody JR; Pishvaian MJ; Yeo CJ
Surg Oncol; 2020 Jun; 33():118-125. PubMed ID: 32561076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]